
<div id="summary">
 
 
 <p><b>Web site</b><br />
 <a href=
 "http://www.usp.org/hqi/mmg/">http://www.usp.org/hqi/mmg/</a></p>
 <p><b>Authority</b><br />
 The Medicare Model Guidelines were developed and are
 maintained by the U.S. Pharmacopeial Convention (USP) in
 conjunction with the Centers for Medicare and Medicaid Services
 (CMS).</p>
 <p><b>Purpose</b><br />
 Medicare Model Guidelines were developed as a result of the
 Medicare Prescription Drug, Improvement, and Modernization Act of
 2003 (MMA) to provide categories and classes of drugs covered by
 Medicare Part D.</p>
 <p><b>Description</b><br />
 Drugs are organized hierarchically by pharmacologic class
 within therapeutic categories. Drugs and their salt and ester
 variations are grouped by drug type within the pharmacologic
 classes.</p>
 <p><b>Audience</b><br />
 Medicare Model Guidelines are used by CMS, Medicare
 beneficiaries, and Part D drug plan companies.</p>
 <p><b>Update Frequency</b><br />
 Medicare Model Guidelines are updated every three years.</p>
<!-- <p><b>Metathesaurus Update Frequency</b><br />
 Medicare Model Guidelines were last updated in the
 Metathesaurus in 2005.</p>-->
 <p><b>Sites Consulted</b></p>
 <ol>
 <li>Medicare Model Guidelines [Internet]. Rockville (MD): The
 United States Pharmacopeial Convention; c2010 [cited 2010 Apr 1].
 Available from: <a href=
 "http://www.usp.org/hqi/mmg/">http://www.usp.org/hqi/mmg/</a>.</li>
 <li>Dill G. Medicare Prescription Drug Benefit: Summary of USP
 approach and methodology to the Model Guidelines Version 4.0
 [Internet]. Rockville (MD): The United States Pharmacopeial
 Convention; c2010 [cited 2010 Apr 5]. 19 p. Available from:
 <a href=
 "http://www.usp.org/pdf/EN/mmg/modelGuidelinesV4SummaryOfApproach.pdf">
 http://www.usp.org/pdf/EN/mmg/modelGuidelinesV4SummaryOfApproach.pdf</a></li>
 </ol>
 
 
 </div>
